Cytomid-250 (Flutamide IP 250 mg) is a prescription antiandrogen medication manufactured by Cipla. It primarily treats advanced prostate cancer by blocking the effects of male hor…
Cytomid-250 (Flutamide IP 250 mg) is a prescription antiandrogen medication manufactured by Cipla. It primarily treats advanced prostate cancer by blocking the effects of male hormones (like testosterone) that fuel cancer cell growth. The medication is taken as directed by a healthcare professional, commonly on a regular schedule throughout the day.
Strength 250 mg
Brand Cytomid
Packaging Size 10*10 Tablets
Dose Type Oral
Form Tablet
Indication Androgen Blockade, Prostate Cancer
Packaging Type Stripe
Manufacturer Cipla
Country of Origin Made in India
Dose 250 mg
Minimum order quantity: 50 Strip
Composition details not available.
We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.
